| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.25 | 3e-11 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.23 | 2e-09 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-08 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.39 | 5e-08 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-07 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.32 | 4e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.22 | 5e-06 |